S. K. Singh, C. Hawkins, I. D. Clarke, J. A. Squire, J. Bayani et al., Identification of human brain tumour initiating cells, Nature, vol.64, issue.7015, pp.396-401, 2004.
DOI : 10.1038/nature03128

J. Miki, B. Furusato, H. Li, Y. Gu, H. Takahashi et al., Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT-Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens, Cancer Research, vol.67, issue.7, pp.3153-3161, 2007.
DOI : 10.1158/0008-5472.CAN-06-4429

S. Yin, J. Li, C. Hu, X. Chen, M. Yao et al., CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity, CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity, pp.1444-1450, 2007.
DOI : 10.1002/ijc.22476

E. Monzani, F. Facchetti, E. Galmozzi, E. Corsini, A. Benetti et al., Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential, European Journal of Cancer, vol.43, issue.5, pp.935-946, 2007.
DOI : 10.1016/j.ejca.2007.01.017

A. Hadnagy, L. Gaboury, R. Beaulieu, and D. Balicki, SP analysis may be used to identify cancer stem cell populations, Experimental Cell Research, vol.312, issue.19, pp.312-3701, 2006.
DOI : 10.1016/j.yexcr.2006.08.030

]. Platet, N. Mayol, J. Berger, F. Herodin, F. Wion et al., Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line, FEBS Letters, vol.294, issue.7, pp.581-1435, 2007.
DOI : 10.1016/j.febslet.2007.02.071

URL : https://hal.archives-ouvertes.fr/inserm-00383790

X. Zheng, G. Shen, X. Yang, and W. Liu, Most C6 Cells Are Cancer Stem Cells: Evidence from Clonal and Population Analyses, Cancer Research, vol.67, issue.8, pp.3691-3698, 2007.
DOI : 10.1158/0008-5472.CAN-06-3912